EP1181315A4 - LAWSONIA DERIVATIVE GENE, FLGE POLYPEPTIDES, PEPTIDES AND PROTEINS AND USES THEREOF - Google Patents

LAWSONIA DERIVATIVE GENE, FLGE POLYPEPTIDES, PEPTIDES AND PROTEINS AND USES THEREOF

Info

Publication number
EP1181315A4
EP1181315A4 EP00924976A EP00924976A EP1181315A4 EP 1181315 A4 EP1181315 A4 EP 1181315A4 EP 00924976 A EP00924976 A EP 00924976A EP 00924976 A EP00924976 A EP 00924976A EP 1181315 A4 EP1181315 A4 EP 1181315A4
Authority
EP
European Patent Office
Prior art keywords
flge
polypeptides
peptides
proteins
derived gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00924976A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1181315A1 (en
Inventor
Michael Panaccio
Everett Lee Rosey
Meri Sinistaj
Detlef Hasse
Jim Parsons
Robert Gerard Ankenbauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agriculture Victoria Services Pty Ltd
Australian Pork Ltd
Pfizer Products Inc
Original Assignee
Agriculture Victoria Services Pty Ltd
Australian Pork Ltd
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agriculture Victoria Services Pty Ltd, Australian Pork Ltd, Pfizer Products Inc filed Critical Agriculture Victoria Services Pty Ltd
Publication of EP1181315A1 publication Critical patent/EP1181315A1/en
Publication of EP1181315A4 publication Critical patent/EP1181315A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP00924976A 1999-05-13 2000-05-11 LAWSONIA DERIVATIVE GENE, FLGE POLYPEPTIDES, PEPTIDES AND PROTEINS AND USES THEREOF Withdrawn EP1181315A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13397399P 1999-05-13 1999-05-13
US133973P 1999-05-13
PCT/AU2000/000437 WO2000069904A1 (en) 1999-05-13 2000-05-11 LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES

Publications (2)

Publication Number Publication Date
EP1181315A1 EP1181315A1 (en) 2002-02-27
EP1181315A4 true EP1181315A4 (en) 2002-08-14

Family

ID=22461178

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00924976A Withdrawn EP1181315A4 (en) 1999-05-13 2000-05-11 LAWSONIA DERIVATIVE GENE, FLGE POLYPEPTIDES, PEPTIDES AND PROTEINS AND USES THEREOF

Country Status (9)

Country Link
EP (1) EP1181315A4 (es)
JP (1) JP2003516113A (es)
AU (1) AU771376B2 (es)
BR (1) BR0011294A (es)
CA (1) CA2372098A1 (es)
MX (1) MXPA01011669A (es)
NZ (1) NZ515331A (es)
PE (1) PE20010316A1 (es)
WO (1) WO2000069904A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605696B1 (en) 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials
DE60144201D1 (de) 2000-12-20 2011-04-21 Intervet Int Bv Lawsonia intracellularis Impfstoff
ATE450545T1 (de) * 2003-09-12 2009-12-15 Intervet Int Bv Impfstoff mit lawsonia intracellularis- untereinheit
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US20100129397A1 (en) 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
CN114712392B (zh) * 2022-05-16 2022-11-25 西部医美生物科技成都有限公司双流医疗分公司 来自自体血液分离的免疫细胞制剂及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
CN1145697C (zh) * 1995-11-30 2004-04-14 维多利亚农业服务控股公司 治疗和诊断组合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
AU771376B2 (en) 2004-03-18
AU4385900A (en) 2000-12-05
EP1181315A1 (en) 2002-02-27
BR0011294A (pt) 2002-02-26
NZ515331A (en) 2003-07-25
PE20010316A1 (es) 2001-03-15
MXPA01011669A (es) 2003-09-10
CA2372098A1 (en) 2000-11-23
JP2003516113A (ja) 2003-05-13
WO2000069904A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
HK1034187A1 (en) Chlamydia protein, gene sequence and uses thereof
IL137921A0 (en) Group b streptococcus proteins and polypeptides
EP0911397A4 (en) TUMORANTANT PROTEINS, THEIR GENES, AND TUMORANTANT PEPTIDES
AU2001232833A1 (en) Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
EP1117436A4 (en) NEISSERIA SPP. POLYPEPTIDES, NUCLEIC ACID SEQUENCE AND THEIR USE
ZA200006309B (en) A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof.
EP1181315A4 (en) LAWSONIA DERIVATIVE GENE, FLGE POLYPEPTIDES, PEPTIDES AND PROTEINS AND USES THEREOF
EP1177212A4 (en) LAWSONIA DERIVATIVE GENE AND RELATED POLYPEPTIDES, PEPTIDES AND SODC PROTEINS, AND USES THEREOF
EP1183268A4 (en) LAWSONIA DERIVED GENES AND RELATED OMPHPOLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
EP1177213A4 (en) LAWSONIA DERIVATIVE GENE, POLYPEPTIDES, PEPTIDES AND HEMOLYSIN PROTEINS AND USES THEREOF
GB9918155D0 (en) Proteins and peptides
EP1210110A4 (en) PROTEINS BINDING TO PRION PROTEIN AND THEIR USE
AU1891301A (en) Novel polypeptide and dna thereof
AU2001241610A1 (en) Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
HUP0201660A2 (en) Novel polypeptide and dna thereof
HK1039636A1 (zh) 髓磷脂碱性蛋白肽及其應用
AU2176997A (en) Novel fused protein, gene therefor, recombinant vector, recombinant virus, and its use
IL145233A0 (en) Recombinant plant proteins and methods utilizing the same
IL135987A0 (en) Lysozyme analogous proteins and peptides, processes for the preparation thereof and compositions and methods utilizing the same
AU6201301A (en) A novel human hepatoma associated protein and the polynucleotide encoding said polypeptide
AU8557801A (en) Modified proteins, isolated novel peptides, and uses thereof
EP1033402A4 (en) P16 BINDING PROTEINS, GENE OF SUCH PROTEINS AND ANTIBODIES AGAINST THESE PROTEINS
AU8748101A (en) A novel polypeptide, a human protein stat2 and the polynucleotide encoding the polypeptide
HUP0102014A3 (en) Human protein c polypeptide
GB9928491D0 (en) Detection of proteins, peptides and polypeptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011114

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20020627

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061201